M
MeiraGTx
New York, United States
Founded 2015 NASDAQ: MGTX
Nanomedicine Gene Therapy Delivery Nano-Bio Cell Therapy Nano Lipid Nanoparticles Protein Nanoparticles
About
Gene therapy for inherited retinal diseases and beyond
Company Details
- Type
- public
- Employees
- 400+
- Funding
- Public
Key Products
- Ophthalmology Gene Therapy